Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program



Status:Active, not recruiting
Conditions:Prostate Cancer, Cancer, Erectile Dysfunction
Therapuetic Areas:Nephrology / Urology, Oncology
Healthy:No
Age Range:21 - Any
Updated:10/6/2018
Start Date:December 2010
End Date:December 2019

Use our guide to learn which trials are right for you!

ACT-ED: Acceptance and Commitment Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program

The investigators know that treatment for prostate cancer and erectile dysfunction can impact
sexual health and quality of life. They want to learn how the treatment affects one's
emotional and social well-being.

They have developed a new type of counseling. Cancer patients seek counseling for lots of
reasons. It often helps them cope because they can express their feelings with a trained
professional. They hope that this counseling will teach patients skills that they can use to
comply with erectile treatment programs, improve their sexual health and quality of life.
These skills may also improve physical and emotional well-being. As part of this study they
will ask the patient to provide feedback on the proposed counseling.


Inclusion Criteria:

Part A

- Men who are 1 to 3 years post radical prostatectomy for early stage prostate cancer

- Participated in penile injection program

- Are able to speak, read, write and understand English well enough to complete study
assessment and communicate with an English speaking therapist

Part B

- Men who are up to 9 months post radical prostatectomy.

- Had good erectile functioning pre-surgery (i.e., 24 or greater on the IIEF Erectile
Function Domain (EFD) score), graded their erections as a 1 or 2 on the standard 5
point Urology Erectile Function scale) or have a score of 7 or greater on the 1-10
pre-surgery erectile function scale on the SMRP assessment)

- Seen at MSKCC‟s Sexual Medicine Rehabilitation Program (SMRP)

- Advised by the clinical staff of the SMRP to start penile injections.

Exclusion Criteria:

Part A

- Recurrence or progression of disease,

- Specific injection phobia (self report)

- A history of bipolar disorder or psychotic disorder (determined from self-report
and/or chart review)

- Current major depression (determined by self report and/or clinician observation and
assessment) that would preclude from giving informed consent or being an active
participant in a focus group

Part B

- Specific injection phobia (self report)

- A history of bipolar disorder or psychotic disorder (determined from self-report
and/or chart review)

- Current major depression (determined by self report and/or clinician observation and
assessment) that would preclude from giving informed consent or being an active
participant in a therapeutic session.
We found this trial at
1
site
1275 York Ave
New York, New York 10021
(212) 639-2000
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials